The relationship of tardive dyskinesia to positive Schizophrenia

References

• Albus M., Nabcr D., Muller-Sphan F., Douillet P., Reinertshofor T., Ackenheil M. Tardive dyskinesia: relation to computer-tomographic, endocrine, and psychopathological variables. Biological Psychiatry 1985; 20: 1082–1089
   PubMedGoogle Scholar
• American Psychiatric Association. DSM-III: Diagnostic and Statistical Manual of Mental Disorders, 3rd. ed. Washington, DC 1980
   Google Scholar
• Andreasen N.C., Smith M. R., Jacoby C. G., Dennert J. W., Olsen S. A. Ventricular enlargement in schizophrenia: Definition and prevalence. American Journal of Psychiatry 1982; 139: 292–296
   PubMed Web of Science ®Google Scholar
• Andreasen N. C. Positive vs. negative symptoms. A critical evaluation. Schizophrenia Bulletin 1985; II: 380–389
   Google Scholar
• Andreasen N.C., Nasrallah H. A., Dunn V., Olscn S., Grove W. M., Erhardt J.C., Coffman J. A., Crossett J. H. W. Structural abnormalities in the frontal system in schizophrenia: A magnetic resonance imaging study. Archives of General Psychiatry 1986; 43: 136–144
   PubMed Web of Science ®Google Scholar
• Angrist B., Rotrosen J., Gershon S. Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia. Psychopharmacology 1980; 11: 1–3
   Google Scholar
• Asso D. WAIS scores in a group of Parkinson patients. British Journal of Psychiatry 1969; 115: 555–556
   PubMed Web of Science ®Google Scholar
• Ayd F. J. A survey of drug-induced extrapyramidal reactions. Journal of the American Medical Association 1961; 175: 1054–1060
   PubMed Web of Science ®Google Scholar
• Baldessarini R. J., Tarsy D. Relationship of the action of neuroleptic drugs to the pathophysiology of tardive dyskinesia. International Review of Neurobiology, J. R. Smythes, R. J. Bradley. Academic Press, New York 1979
   Google Scholar
• Baldessarini R. J. Dopamine and the pathophysiology of dyskinesias induced by antipsychotic drugs. Annual Review of Neuroscience 1980; 3: 23–41
   PubMed Web of Science ®Google Scholar
• Barnes T. R., Ross M., Trauer T. A comparison of purposeless movements in psychiatric patients treated with antipsychotic drugs, and normal individuals. Journal of Neurology, Neurosurgery and Psychiatry 1983; 46: 540–546
   PubMed Web of Science ®Google Scholar
• Barr M. L. The human nervous system 3rd. ed. Harper & Row, Hagerstown, MD 1979
   Google Scholar
• Bartels M., Themelis J. Computerized tomography in tardive dyskinesia. Archivfur Psychiatric unci Nervenkrankheilen 1983; 233: 371–379
   PubMedGoogle Scholar
• Bentin S., Silverberg R., Gordon H. W. Asymmetrical cognitive deterioration in demented and parkinson patients. Cortex 1981; 17: 533–544
   PubMed Web of Science ®Google Scholar
• Blumer D., Benson D. Personality changes in frontal and temporal lobe lesions. Psychiatric aspects of neurologic diseases, D. Benson, D. Blumer. Grune and Stratton, New York 1975; 151–170
   Google Scholar
• Boiler F., Passafiume D., Keefe N.C., Rogers K., Morrow L., Kim Y. Visuospatial impairment in Parkinson's disease. Role of perceptual and motor factors. Archives of Neurology 1984; 41: 485–490
   PubMedGoogle Scholar
• Bowen F. P., Hoehn M. M., Yahr M. D. Parkinsonism: alterations in spatial orientation as determined by a route-walking test. Neuropsychologia 1972; 10: 355–361
   PubMed Web of Science ®Google Scholar
• Brainin M., Reisner T., Zeitelhofer J. Tardive dyskinesia: clinical correlation with computed tomography in patients aged less than 60 years. Journal of Neurology, Neurosurgery and Psychiatry 1983; 46: 1037–1040
   PubMedGoogle Scholar
• Brambilla F., Guastala A., Guerrini A., Riggi F., Rovere C, Zanobini A., Zanoboni-Muciaccia W. Glucose-insulin metabolism in chronic schizophrenia. Diseases of the Nervous System 1976; 37: 98–103
   PubMedGoogle Scholar
• Burke R. E. Tardive dyskinesia: Current clinical issues. Neurology 1984; 34: 1348–1353
   PubMed Web of Science ®Google Scholar
• Cannon T. D., Fuhrmann M., Mednick S. A., Machon R. A., Parnas J., Schulsinger F. Third ventricular enlargement and reduced electrodermal responsiveness. Psychophyswlogy 1988; 25: 153–156
   PubMed Web of Science ®Google Scholar
• Casey D. E., Denney D. Pharmacological characterisation of tardive dyskinesia. Psychopharmacology 1977; 54: 1–9
   PubMed Web of Science ®Google Scholar
• Casey D. E. Managing tardive dyskinesia. Journal of Clinical Psychiatry 1978; 39: 748–753
   PubMedGoogle Scholar
• Casey D. Tardive dyskinesia: Reversible and irreversible. Dyskinesia: Research and treatment, D. E. Casey, T. Chase, A. V. Christensen, J. Gerlach. Springer, Berlin 1985; 88–96
   Google Scholar
• Casey D. Tardive dyskinesia. Psychopharmacology: the third generation of progress, H. Y. Meltzer. Raven Press, New York 1987; 1411–1419
   Google Scholar
• Crow T. J. Molecular pathology of schizophrenia: More than one disease process. British Medical Journal 1980; 280: 66–68
   PubMed Web of Science ®Google Scholar
• Crow T. J. Schizophrenia. Disorders of neurohumoral transmission, T. J. Crow. Academic Press, London 1982; 287
   Google Scholar
• Crow T. J. Two syndromes in schizophrenia. Trends in Neurosciences 1982a; 5: 351–354
   Google Scholar
• Crow T. J. The two syndrome concept: Origins and current status. Schizophrenia Bulletin 1985; 11: 471–486
   PubMed Web of Science ®Google Scholar
• Cox S. M., Ludwig A. M. Neurological soft signs and psychopathology: Findings in schizophrenia. Journal of Nervous and Menial Disease 1979; 167: 161–165
   PubMed Web of Science ®Google Scholar
• Cushing H. The pituitary body and hypothalamus. Charles C. Thomas, Springfield, Illinois 1929
   Google Scholar
• Davis J. M. Comparative doses and costs of antipsychotic medication. Archives of General Psychiatry 1976; 33: 858–861
   PubMed Web of Science ®Google Scholar
• DeRenzi E., Faglioni P., Scotti G. Hemisperic contribution to exploration of space through the visual and tactile modality. Cortex 1970; 6: 191–203
   PubMedGoogle Scholar
• Dewan M. J., Pandurangi A. K., Lee S. H., Ramachandran T., Levy B., Boucher M., Yozawitz A., Major L. F. Central brain morphology in chronic schizophrenic patients: A controlled CT study. Biological Psychiatry 1983; 18: 1133–1140
   PubMed Web of Science ®Google Scholar
• Dimond S., Beaumont J. Hemispheric function in the human brain. Halstead, New York 1974
   Google Scholar
• Direnfield L. K., Albert M. L., Volicer L., Langlais P. J., Marquis J., Kaplan E. Parkinson disease. The possible relationship of laterality to dementia and neurochemical findings. Archives of Neurology 1984; 41: 935–941
   PubMedGoogle Scholar
• Ewald G. Vegetatives System und Psychiatrie. Fortschrile der Neurologic und Psychiatric 1950; 18: 577–605
   Google Scholar
• Edwards H. The significance of brain damage in persistent oral dyskinesia. British Journal of Psychiatry 1970; 116: 271–275
   PubMedGoogle Scholar
• Fanget F., Claustrat B., Dalery J., Brun J., Terra J. L., Marie-Cardine M., Guyotat J. Noturnal plasma melatonin levels in schizophrenic patients. Biological Psychiatry 1989; 25: 499–501
   PubMed Web of Science ®Google Scholar
• Ferrier I. N., Arendt J., Johnstone E. C. Reduced nocturnal melatonin secretion in chronic schizophrenia: Relationship to body weight. Clinical Endocrinology 1982a; 17: 181–187
   PubMed Web of Science ®Google Scholar
• Ferrier I. N., Cotes P. M., Crow T. J., Johnstone E. C. Gonadotrophin secretion abnormalities in chronic schizophrenia. Psychological Medicine 1982b; 12: 263–273
   PubMed Web of Science ®Google Scholar
• Fumuyiwa O. O., Eccleston D., Donaldson A. A., Garside R. F. Tardive dyskinesia and dementia. British Journal of Psychiatry 1979; 135: 500–504
   PubMedGoogle Scholar
• Gay N., Cottraux J. A., Denoroy L., Tommasi M., Kopp N. Possible increase of dopamine-beta-hydroxylase activity in the locus coeruleus of paranoid schizophrenic patients: A preliminary post-mortem study. Psychiatry Research 1989; 27: 31–38
   PubMed Web of Science ®Google Scholar
• Gerlach J. Pathophysiological mechanisms underlying tardive dyskinesia. Dyskinesia: research and treatment, D. E. Casey, T. N. Chase, A. V. Christensen, J. Gerlach. Springer-Verlag, Berlin 1985; 98–103
   Google Scholar
• Geschwind N., Levitsky W. Human brain: left right asymmetries in temporal speech region. Science 1968; 161: 186–197
   PubMed Web of Science ®Google Scholar
• Glick S. D., Ross D. A., Hough L. H. Lateral asymmetry of neurotransmitters in human brain. Brain Research 1982; 234: 53–63
   PubMed Web of Science ®Google Scholar
• Gluck E., Radu E. W., Mundt C., Gerhardt P. A computed tomographic prolective trohoc study of chronic schizophrenia. Neuroradiology 1980; 20: 167–171
   PubMedGoogle Scholar
• Gross G., Gruber G., Schuttler R. Computerized tomography studies on schizophrenic diseases. Archives für Psychiatrie und Nervenkrankheiten 1982; 231: 519–526
   PubMedGoogle Scholar
• Gureje O. Topographic subtypes of tardive dyskinesiain schizophrenic patients aged less than 60 years: Relationship to demographic, clinical, treatment, and neuropsychological variables. Journal of Neurology, Neurosurgery and Psychiatry 1988; 51: 1525–1530
   PubMed Web of Science ®Google Scholar
• Gureje O. Y. E. The significance of subtyping tardive dyskinesia: a study of prevalence and associated factors. Psychological Medicine 1989; 19: 121–128
   PubMed Web of Science ®Google Scholar
• Heilman K. M., Valenstein E. Mechanisms underlying hemispatial neglect. Annals of Neurology 1979; 5: 166–170
   PubMed Web of Science ®Google Scholar
• Hoffman W. F., Labs S. M., Casey D. E. Neuroleptic-induced parkinsonism in older schizophrenics. Biological Psychiatry 1987; 22: 427–439
   PubMed Web of Science ®Google Scholar
• Horn S. Some psychological factors in parkinsonism. Journal of Neurology, Neurosurgery and Psychiatry 1974; 37: 27–31
   PubMed Web of Science ®Google Scholar
• Houston J. P., Maas J. W., Bowden C. L., Contreras S. A., McLntyre K. L., Javors M. A. Cerbrospinal fluid HVA, central brain atrophy, and clinical state in schizophrenia. Psychiatry Research 1986; 19: 207–214
   PubMed Web of Science ®Google Scholar
• Hovestadt A., De Jong G. J., Meerwaldt J. D. Spatial disorientation as an early symptom of Parkinson's disease. Neurology 1987; 37: 485–487
   PubMed Web of Science ®Google Scholar
• Hovestadt A., De Jong G. J., Meerwaldt J. D. Spatial disorientation in Parkinson's disease: No effect of levopopa substitution therapy. Neurology 1988; 38: 1802–1803
   PubMed Web of Science ®Google Scholar
• Huber G. Indizien fur die Somatosehypothese bei den Schizophrenien. Fortschrifte der Neurologie und Psychiatrie 1976; 44: 11–94
   Google Scholar
• Iager A.C., Kirch D. G., Wyatt J. A negative symptom rating scale. Psychiatry Research 1985; 27–36
   PubMedGoogle Scholar
• Illowsky B., Kirch D. Polydipsia and hyponatremia in psychiatric patients. American Journal of Psychiatry 1988; 145: 675–683
   PubMed Web of Science ®Google Scholar
• Incagnoli T., Kane R. Neuropsychological functioning in Tourette's syndrome. Advances in Neurology 1982; 35: 305–309
   PubMedGoogle Scholar
• Jacquet Y. F., Abrams G. M. Postural asymmetry and movement disorder after unilateral microinjection of ACTH 1–24 in rat brainstem. Science 1982; 218: 175–177
   PubMed Web of Science ®Google Scholar
• Jacobi W., Winkler H. Encephalographische Studien am chronisch Schizophrenen. Archives für Psychiatrie und Nervenkrankheiten 1927; 81: 299–332
   Google Scholar
• Jeste D. V., Wyatt R. J. Therapeutic strategies against tardive dyskinesia. Archives of General Psychiatry 1982; 39: 803–816
   PubMed Web of Science ®Google Scholar
• Jeste D. V., Doongaji D. R., Linnoila M. Elevated cerebrosphinal fluid noradrenaline in tardive dyskinesia. British Journal of Psychiatry 1984; 144: 177–180
   PubMed Web of Science ®Google Scholar
• Johnstone E.C., Crow T. J., Frith C. D., Husband J., Kreel L. Cerebral ventricular size and cognitive impairment in chronic schizophrenia. Lancet 1976; 2: 924–926
   PubMed Web of Science ®Google Scholar
• Johnstone E.C., Crow T. J., Ferrier I. N., Frith C. D., Owens D. G.C., Bourne R. C., Gamble S. J. Adverse effects of anticholinergic medication on positive schizophrenic symptoms. Psychological Medicine 1983; 13: 513–527
   PubMed Web of Science ®Google Scholar
• Kane J. M., Smith J. M. Tardive dyskinesia: Prevalence and risk factors. 1959–1979. Archives of General Psychiatry 1982; 39: 473–481
   PubMed Web of Science ®Google Scholar
• Kane J. M., Woerner M., Lieberman J. Tardive dyskinesia: prevalence, incidencem, and risk factors. Journal of Clinical Psychopharmacology 1988; 8: 52S–56S, (suppl)
   PubMed Web of Science ®Google Scholar
• Kaufman C. A., Jeste D. V., Shelton R.C., Linnoila M., Kafka M. S., Wyatt R. J. Noradrenergic and neuroradiological abnormalities in tardive dyskinesia. Biological Psychiatry 1986; 21: 799–812
   PubMed Web of Science ®Google Scholar
• Katz D. I., Alexander M. P., Mandell A. M. Dementia following strokes in the mesencephalon and diencephalon. Archives of Neurology 1987; 44: 1127–1133
   PubMedGoogle Scholar
• Kay S. R., Opler L. A., Fiszbein A. Significance of positive and negative syndromes in chronic schizophrenia. British Journal of Psychiatry 1986; 149: 439–448
   PubMed Web of Science ®Google Scholar
• Kennedy P. F., Hershon H. I., McGuire R. J. Extrapyramidal disorders after prolonged phenothiazine therapy. British Journal of Psychiatry 1971; 118: 509–518
   PubMed Web of Science ®Google Scholar
• Kidger T., Barnes T. R. E., Trauer T., Taylor P. J. Sub-syndromes of tardive dyskinesia. Psychological Medicine 1980; 10: 513–520
   PubMed Web of Science ®Google Scholar
• Klawans H. L. The pharmacology of tardive dyskinesia. American Journal of Psychiatry 1973; 130: 82–86
   PubMed Web of Science ®Google Scholar
• Klawans H. L., Rubovits R. The effect of cholinergic and anticholinergic agents on tardive dyskinesia. Journal of Neurology. Neurosurgery and Psychiatry 1974; 37: 941–947
   PubMedGoogle Scholar
• Kolakowska T., Williams A. D., Ardern M., Reveley M. A. Tardive dyskinesia in schizophrenics under 60 years of age. Biological Psychiatry 1986; 21: 161–169
   PubMedGoogle Scholar
• Kraepelin E. Dementia Praecox and Paraphenia. Krieger Publishing Co, New York 1919
   Google Scholar
• Krawiecka M., Goldberg D., Vaughan M. A. Standardized psychiatric assessment for rating chronic patients. Acta Psychiatrica Scandinavica 1977; 55: 299–308
   PubMed Web of Science ®Google Scholar
• Langston J. W., Forno L. S. The hypothalamus in Parkinson's disease. Annals of Neurology 1978; 3: 129–133
   PubMed Web of Science ®Google Scholar
• Lesch A., Bogerts B. The diencephalon in schizophrenia: Evidence for reduced thickness of the periventricular grey matter. European Archives of Psychiatry and Neurological Services 1984; 234: 212–219
   PubMedGoogle Scholar
• Lindvall O., Bjorklund A., Moore R. V., Stenevi U. Mesencephalic dopamine neurons projecting to the neocortex. Brain Research 1974; 81: 325–331
   PubMed Web of Science ®Google Scholar
• Loranger A. W., Goodell H., McDowell F. H., Lee J. E., Sweet R. D. Intellectual impairment in Parkinson's disease. Brain 1972; 95: 405–412
   PubMed Web of Science ®Google Scholar
• Luchins D. J., Jackman H., Meltzer H. Y. Lateral ventricular size and drug-induced parkinsonism. Psychiatry Research 1983; 9: 9–16
   PubMed Web of Science ®Google Scholar
• Luria A. R. Higher cortical functions in man. Basic Books Inc. Publishers, New York 1966
   Google Scholar
• MacKay A. V. P. Positive and negative schizophrenic symptoms and the role of dopamine: Discussion, 1. British Journal of Psychiatry 1980; 137: 379–383
   PubMed Web of Science ®Google Scholar
• Manschreck T. C. Psychopathology of motor behaviour in schizophrenia. Progress in Experimental Personality Research 1983; 12: 53–94
   PubMedGoogle Scholar
• Marshall J. F., Turner B. H., Teitelbaum P. Sensory neglect produced by lateral hypothalamic damge. Science 1971; 174: 523–525
   PubMed Web of Science ®Google Scholar
• Marsden C. D., Jenner P. The pathophysiological of extrapyramidal side-effects of neuroleptic drugs. Psychological Medicine 1975; 10: 55–72
   Google Scholar
• McCarley R. W., Faux S. F., Shenton M., LeMay M., Cane M., Ballinger R., Duffy F. H. CT abnormalities in schizophrenia. A preliminary study of their correlation with P300/P200 electrophysiological features and positive/negative symptoms. Archives of General Psychiatry 1989; 46: 698–708
   PubMedGoogle Scholar
• Mesulam N. M. A cortical network for directed attention and unilateral neglect. Annals of Neurology 1981; 10: 309–325
   PubMed Web of Science ®Google Scholar
• Milner B. Hemispheric specialization: scope and limits. The neuroscience third study program, F. O. Schmitt, F. G. Warden. MIT Press, Cambridge 1973; 75–80
   Google Scholar
• Miwa S., Inagaki C, Fujewara M., Takaori S. The activities of noradrenergic and dopaminergic neurons systems in experimental hydrocephalus. Journal of Neurosurgery 1982; 57: 67–73
   PubMed Web of Science ®Google Scholar
• Mortimer J. A., Pirozzolo F. J., Hansch E. C., Webster D. D. Relationship of motor symptoms to intellectual deficits in Parkinson's disease. Neurology 1982; 32: 133–137
   PubMed Web of Science ®Google Scholar
• Myslobodsky M., Weiner M. Pharmacologic implication of hemisphreic asymmetry. Life Sciences 1976; 19: 1467–1478
   PubMed Web of Science ®Google Scholar
• Nasrallah H. A., Jacoby C. G., Chapman S., McCalley-Whitters M. Third ventricular enlargement on CT scans in schizophrenia: Association with cerebellar atrophy. Biological Psychiatry 1985; 20: 443–450
   PubMed Web of Science ®Google Scholar
• Nauta W. J. H., Feirtag M. Fundamental neuroanatomy. WH Freemartson, New York 1986; 120–131
   Google Scholar
• Nieto D., Escobar A. Major Psychoses. Pathology of the nervous system, J. Minckler. McGraw-Hill, New York 1972; 2654–2665
   Google Scholar
• Nyback H., Wiesel F. A., Berggren B. M., Hindmarsh T. Computed tomography of the brain in patients with acute psychosis and in healthy volunteers. Acta Psychiatrica Scandinavica 1982; 65: 403–413
   PubMed Web of Science ®Google Scholar
• Okasha A., Madkour O. Cortical and central atrophy in chronic schizophrenia. Acta Psychiatrica Scandinavica 1982; 65: 29–34
   PubMedGoogle Scholar
• Oleson J. Contralateral focal increase of cerebral blood flow in man during arm work. Brain 1971; 94: 635–646
   PubMedGoogle Scholar
• Opler L. A., Kay S. R., Rosado V., Lindenmayer J. P. Positive and negative syndromes in chronic schizophrenic inpatients. Journal of Nervous and Mental Disease 1984; 172: 312–315
   Google Scholar
• Overall J. E., Gorham D. R. Brief psychiatric rating scale. Psychological Reports 1962; 10: 799–812
   Web of Science ®Google Scholar
• Owens D. G.C., Johnstone E.C., Crow T. J., Frith C. D., Jagoe J. R., Kreel L. Lateral ventricular size in schizophrenia: relationship to the disease process and its clinical manifestations. Psychological Medicine 1985; 15: 27–41
   PubMed Web of Science ®Google Scholar
• Pirozzolo F. J., Hansch E. C., Mortimer J. A. Dementia in Parkinson's disease: A Neuropsychological analysis. Brain and Cogntion 1982; 1: 71–83
   PubMedGoogle Scholar
• Plum F., Van Uitert R. Nonendocrine diseases and disorders of the hypothalamus. The hypothalamus, S. Reichlin, R. J. Balderessarini, J. B. Martin. Raven Press, New York 1987; 415–473
   Google Scholar
• Proctor F., Riklan M., Cooper S. T., Teuber H. L. Judgment of Visual and postural vertical by Parkinsonism patients. Neurology 1964; 14: 287–293
   PubMed Web of Science ®Google Scholar
• Robinson R. G. Differential behavioral and biochemical effects of right and left hemispheric cerebral infarction in the rat. Science 1979; 205: 707–710
   PubMed Web of Science ®Google Scholar
• Ross E. D., Stewart R. M. Akinetic mutism from hypothalamic damage: successful treatment with dopamine agonists. Neurology 1981; 31: 1435–1439
   PubMed Web of Science ®Google Scholar
• Saffer D., Metcalfe M., Coppen A. Abnormal dexamethasone suppression test in type II schizophrenia. British Journal of Psychiatrym 1985; 147: 721–723
   PubMed Web of Science ®Google Scholar
• Salzman C. Clinical Geriatric Psychopharmacology. McGraw-Hill, New York 1984
   Google Scholar
• Sandyk R. Autoimmune mechanisms in Parkinson's disease. International Journal of Neuroscience 1989; 48: 369–372
   PubMed Web of Science ®Google Scholar
• Sandyk R., Iacono R. P. Hypothalamic-mediated immune mechanisms and their relevance to the pathoetiology of Parkinson's disease. International Journal of Neuroscience 1986; 32: 979–981
   Web of Science ®Google Scholar
• Sandyk R., Iacono R. P., Bamford C. R. The hypothalamius in Parkinson's disease. Italian Journal of Neurological Sciences 1987; 8: 227–234
   PubMedGoogle Scholar
• Sandyk R., Kay S. R. The role of pineal melatonin functions in the pathophysiology of schizophrenia. A review and hypothesis. Schizophrenia Bulletin, in press a
   Google Scholar
• Sandyk R., Kay S. R. Interpretation of the positive-negative distinction. Positive and Negative Syndromes in Schizophrenia: Assessment and Research, S. R. Kay. Brunner/ Mazel, New York, in press b
   Google Scholar
• Sandyk R., Kay S. R. Subjective awareness of abnormal involuntary movements in schizophrenic patients with tardive dyskinesia. International Journal of Neuroscience, in press c
   Google Scholar
• Sandyk R., Kay S. R. The effects of anticholinergic therapy on tardive dyskinesia. International Journal of Neuroscience, in pressd
   Google Scholar
• Schooler N. R., Kane J. M. Research diagnoses of tardive dyskinesia. Archives of General Psychiatry 1982; 39: 486–487
   PubMed Web of Science ®Google Scholar
• Shapiro E., Shapiro A. K., Clarkin J. Clinical psychological testing in Tourette's syndrome. Journal of Personality Assessment 1974; 38: 364–378
   Google Scholar
• Shelton R.C., Karson K. N., Doran A. R., Pickar D., Bigelow L. B., Weinberger D. R. Cerebral structural pathology in schizophrenia: evidence for a selected prefrontal cortical defect. American Journal of Psychiatry 1988; 145: 154–163
   PubMed Web of Science ®Google Scholar
• Simpson G. M., Lee J. H., Zoubok B., Gardos G. A rating scale for tardive dyskinesia. Pyschopharmacology 1979; 64: 171–179
   PubMed Web of Science ®Google Scholar
• Singh M. M., Kay S. R. A comparative study of haloperidol and chlorpromazine in terms of clinical effects and therapeutic reversal with benztropine in schizophrenia: Theoretical implications for potency differences among neuroleptics. Psyehopharmacologia 1975; 43: 103–113
   PubMedGoogle Scholar
• Singh M. M., Kay S. R., Opler L. A. Anticholinergic-neuroleptic antagonism in terms of positive and negative symptoms of schizophrenia: Implications for psychobiological subtyping. Psychological Medicine 1987; 17: 39–48
   PubMed Web of Science ®Google Scholar
• Sommers A. A. “Negative symptoms”: Conceptual and methodological problems. Schizophrenia Bulletin 1985; 11: 364–379
   PubMed Web of Science ®Google Scholar
• Stevens J. Neuropathology of schizophrenia. Archives of General Psychiatry 1982; 39: 1131–1139
   PubMed Web of Science ®Google Scholar
• Struve F. A., Willner A. E. Cognitive dysfunction and tardive dyskinesia. British Journal of Psychiatry 1984; 143: 597–600
   Web of Science ®Google Scholar
• Sutherland R. J., Kolb B., Schoel W. M., Whishaw I. Q., Davies D. Neuropsychological assessment of children and adults with Tourette's syndrome:A comparison with learning disabilities and schizophrenia. Advances in Neurology 1982; 35: 311–322
   PubMedGoogle Scholar
• Swayze V. W., Yates W. R., Andreasen N. C., Allinger R. J. CT abnormalities in tardive dyskinesia. Psychiatry Research 1988; 26: 51–58
   PubMedGoogle Scholar
• Swelt C. Drug-induced dystonia. American Journal of Psychiatry 1975; 132: 532–534
   PubMedGoogle Scholar
• Synek V., Reuben J. R. The ventricular brain ratio using planimetric measurements of EMI scans. British Journal of Radiology 1976; 49: 233–237
   PubMed Web of Science ®Google Scholar
• Tanaka Y., Hazama H., Kawahara R., Kobayashi K. Computerized tomography of the brain in schizophrenic patients. Acta Psychiatrica Scandinavica 1981; 63: 191–197
   PubMed Web of Science ®Google Scholar
• Tandon R., Greden J. F. Cholinergic hyperactivity and negative schizophrenic symptoms. A model of cholinergic/dopaminergic interactions in schizophrenia. Archives of General Psychiatry 1989; 46: 745–753
   PubMed Web of Science ®Google Scholar
• Tandon R., Goodson J., Silk K. R., Kronfol Z., Hariharan M., Greden J. F. Postive and negative symptoms in schizophrenia and the dexamethasone suppression test. Biological Psychiatry 1989; 25: 788–791
   PubMed Web of Science ®Google Scholar
• Tanner C. M. Drug-induced movement disorders (tardive dyskinesia and dopa-induced dyskinesia). Handbook of clinical neurology: extrapyramidal disorders, P. J. Vinken, G. W. Bruyn, H. L. Klawans. Elsevier Science Publishers, Amsterdam 1986; vol 49: 185–204
   Google Scholar
• Van Kanimen D. P., Van Kammen W. B., Mann L. S., Seppala T., Linnoila M. Dopamine metabolism in cerebrospinal fluid of drug-free schizophrenic patients with and without cortical atrophy. Archives of General Psychiatry 1986; 43: 978–983
   PubMedGoogle Scholar
• Villadita C, Smirni P., Zappala G. Visual neglect in Parkinson's disease. Archives of Neurology 1983; 40: 737–739
   PubMedGoogle Scholar
• Waddington J. L. Aspects of the neurobiology and psyehopaharmacology of schizophrenia, with particular reference to involuntary movements (tardive dyskinesia): anomalies and controversies. Progress in Clinical Neuroscience 1985; 2: 20–30
   Google Scholar
• Waddington J. L., Youssef H. A. An unusual cluster of tardive dyskinesia in schizophrenic: Association with cognitive dysfunction and negative symptoms. American Journal of Psychiatry 1986a; 143: 1162–1165
   PubMed Web of Science ®Google Scholar
• Waddington J. L., Youssef H. A. Late onset involuntary movements in chronic schizophrenia: relationship of “tardive” dyskinesia to intellectual impairment and negative symptoms. British Journal of Psychiatry 1986b; 149: 616–620
   PubMed Web of Science ®Google Scholar
• Waddington J.L., Youssef H. A., Dolphin C., Kinsella A. Cognitive dysfunction, negative symptoms, and tardive dyskinesia in schizophrenia. Archives of General Psychiatry 1987; 44: 907–912
   PubMed Web of Science ®Google Scholar
• Waldhauser F., Steger H. Changes in melatonin secretion with age and pubescence. Journal of Neural Transmission 1968; 21: 183–197, (suppl)
   Google Scholar
• Walton J. Disorders of memory. Brain's diseases of the nervous system 9th Edition, J. Walton. Oxford University Press. 1985; 655
   Google Scholar
• Waziri R. Lateralization of neuroleptic-induced dyskinesia indicates pharmacologic asymmetry in the brain. Psychopharmacology 1980; 68: 51–53
   PubMed Web of Science ®Google Scholar
• Wegner J. T., Kane J. M., Weinhold P., Woerner M., Kinon B., Lieberman J. Cognitive impairment in tardive dyskinesia. Psychiatry Research 1985; 16: 331–337
   PubMed Web of Science ®Google Scholar
• Wiegnat V. M., Verhoef C. J., Burbach P. H., De Wied D. Increased concentration of alpha and sigma-endorphin in post mortem hypothalamnic tissue of schizophrenic patients. Life Sciences 1988; 42: 1733–1742
   PubMedGoogle Scholar
• Wise C. D., Stein L. Dopamine beta-hydroxylase deficit in the brain of schizophrenic patients. Science 1973; 181: 344–347
   PubMed Web of Science ®Google Scholar
• Wolf M. E., Ryan J. J., Mosnaim A. D. Cognitive functions in tardive dyskinesia. Psychological Medicine 1983; 13: 671–674
   PubMed Web of Science ®Google Scholar
• Woddard J. S. Concentric hyaline inclusion body formation in mental disease analysis of twenty-seven cases. Journal of Neuropathology and Experimental Neurology 1962; 21: 442–449
   PubMedGoogle Scholar
• Youssef H. A., Waddington J. L. Primitive (developmental) reflexes and diffuse cerebral dysfunction in schizophrenia and bipolar affective disorder: Overrepresentation in patients with tardive dyskinesia. Biological Psychiatry 1988; 23: 791–796
   PubMed Web of Science ®Google Scholar